US Patent Issued to VACCINEX on June 30 for "Human anti-semaphorin 4D antibody" (New York Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,630, issued on June 30, was assigned to VACCINEX INC. (Rochester, N.Y.).

"Human anti-semaphorin 4D antibody" was invented by Ernest S. Smith (W. Henrietta, N.Y.), Angelica Cornelison (Pittsford, N.Y.), Maria Scrivens (Rochester, N.Y.), Mark Paris (Mendon, N.Y.) and Maurice Zauderer (Pittsford, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and method are provided for treating diseases associated with semaphorin-4D (SEMA4D) pathology, including autoimmune diseases, inflammatory diseases, cancers, neuroinflammatory disorders and neurodegenerative diseases."

The patent was filed on May 3, 2024, under Application No. 18/654,538.

*For...